The Cardiology

115
Views

0
Downloads

Introduction to New Oral Anticoagulants (NOAC’s)

Rohan Jayasinghe, Ryan Markham, Kais Hyasat and Geoff Adsett
Page: 7-10 | Received 21 Sep 2022, Published online: 21 Sep 2022

By Research Area

Medicine & Public Health Life Sciences Engineering Mathematics Biomedicine Physics Chemistry Computer Science Earth Sciences Social Sciences Business and Management Psychology Materials Science Economics Education Environment Philosophy Statistics Law Political Science and International Relations Pharmacy Dentistry Energy Linguistics Geography Finance Criminology and Criminal Justice Medicine Cultural and Media Studies History Architecture / Design Literature Biomedical Sciences Religious Studies Education & Language Food Science & Nutrition Public Health

By Volume and Issue

Abstract

To produce a high quality article for physicians that reviews the current literature pertaining to NOAC’s, in particular, their use in clinical practice, known drug interactions and side effect profile. Medline, Cochrane and PubMed databases were searched for the most recent and clinically sound articles pertaining apixaban, rivaroxaban and dabigatran. Researchers found the trials for each of these NOAC’s to be sound and have results that can be translated into clinical practice.

How to cite this article:

Rohan Jayasinghe, Ryan Markham, Kais Hyasat and Geoff Adsett. Introduction to New Oral Anticoagulants (NOAC’s).
DOI: https://doi.org/10.36478/tcard.2014.7.10
URL: https://www.makhillpublications.co/view-article/1811-8194/tcard.2014.7.10